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1. Introduction 
The dihydrochloride salt of 2,7-bis (2-(diethyl- 
amino) ethoxy)- fluoren-9-one, referred to as tilorone 
hydrochloride or bis-DEAE-fluorenone (DEAE-F), is 
a broad spectrum antiviral compound [ 1 ] with anti- 
tumor activity [2,3]. Mayer and coworkers [4,5] 
have identified this compound as an interferon in- 
ducer and established a relationship with the antiviral 
activity. To our knowledge, nothing is yet known 
about the molecular mechanism of action of this com- 
pound. This report describes the action of DEAE-F on 
the DNA polymerases from mammalian RNA tumor 
viruses, FLV (Friend) and MSV (Moloney). We find 
that in both systems DEAE-F is a very potent in- 
hibitor of DNA polymerases. This inhibition is unique- 
ly and selectively dependent on the type of primer- 
template used in the assay system. The reactions cata- 
lyzed by poly(dA-dT), poly (rA.dT) and poly rA. 
(dT) 12 are highly sensitive to DEAE-F inhibition, 
whereas in the presence of poly (dI.dC) DEAE-F was 
found to stimulate 3HdGMP incorporation into DNA. 
2. Materials and methods 
Labeled deoxynucleoside triphosphates were ob- 
tained from NEN-Chemicals GmbH, Germany. Poly 
(dA-dT) and poly rA were supplied by Miles Labora- 
tories, Elkhart, Indiana, USA. Poly (dI.dC) and poly 
rA.(dT)lz were provided by Dr. G. Weimann of 
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Boehringer Mannheim, GmbH. Bis-DEAE-fluorenone 
was a gift of Merrel & Co. to Prof. C.L. Fox. 
MSV(Moloney), kindly supplied by Dr. J.B. Mol- 
oney (NCI, Bethesda, Md.) was passed by intramus- 
cular injection into suckling Swiss mice, and extracted 
from the tumor tissue. Friend Leukemia Virions 
(FLV) were isolated from infected spleens (AKR 
mice) and purified by sucrose-density gradient centri- 
fugation. The viral extracts used to assay for DNA- 
polymerase activity were stored at -70” before use. 
DNA polymerase activity was assayed essentially 
by the method of Ross et al. [6] . The reaction mix- 
ture, regardless of template, was similar to that of 
Ross et al. [6], except that we used 0.04 M Tris and 
the end concentration of Nonidet P-40 was 0.2%. The 
reaction mixture contained 0.25 pg of the template 
used. Reaction mixtures (~010.25 ml) containing 
virions (12-15 pg protein) were incubated at 37” for 
90 min. Acid precipitable material was counted on 
“Millipore” filters (HAWP 02500) in a liquid scintil- 
lation counter. Protein was estimated by the method 
of Lowry et al. [7]. 
3. Results and discussion 
Munson et al. [3] have recently shown that DEAE-F 
is effective in inhibiting the established Friend viral 
leukemia. They believe that interferon induction may 
not be responsible for the antitumor activity of this 
compound. This suggests that the virus-associated en- 
zymatic activities, DNA polymerases, may be sensitive 
towards the action of DEAE-F. Table 1 shows the in- 
hibition of reverse-transcriptase activity from MSV 
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Fig. 1. Chemical structure of bis_DEAE-fluorenone. 
(Moloney) and FLV(Friend) by DEAE-F. 
Results presented in table 1 show that the in vitro 
system is dependent on the source of enzyme, i.e. 
virions, and sensitive to RNase. Preincubation of 
virions with RNase blocks their activity to synthesize 
DNA. This shows that the endogenic template, viral 
RNA, is required for the synthesis of DNA. DEAE-F 
added to the reaction mixture inhibits the DNA-poly- 
merase activity in MSV(M) and FLV. At low concen- 
trations (5 pg/reaction mixt.) of DEAE-F the MSV(M) 
system is more sensitive than FLV. However, at higher 
concentrations of DEAF-F the inhibition in both the 
systems is of the same magnitude. It is interesting to 
note that concentrations as low as 20 pgjreaction mixt. 
are able to inhibit approximately 70% of incorporation 
of 3H-TMP into DNA. 
Synthetic polymers containing either deoxyribo- 
nucleotide or ribonucleotide strands are known to 
stimulate the in vitro DNA synthesis by RNA tumor 
viruses [8,9]. Some inhibitors of the DNA-polymerase 
reaction in RNA tumor viruses are known to exhibit 
a template-primer specificity [lo-l 21. Table 2 shows 
the inhibition of template-dependent DNA polymerase 
activity of FLV by DEAE-F at various concentrations. 
The reaction catalyzed by poly (dA-dT) is most 
sensitive to the action of DEAE-F. At 5 pg/reaction 
mixt. of DEAE-F more than 80% inhibition of 3H-TMP 
incorporation was seen. Reactions catalyzed by poly 
(rA.dT) and poly rA.(dT)rz are not inhibited at this 
concentration of DEAE-F. However, at higher concen- 
trations the reactions are very sensitive towards DEAE- 
F. Compared to poly (rA.dT), the reaction catalyzed 
by poly rA.(dT)iz is more sensitive to DEAE-F action. 
Surprisingly, the reaction catalyzed by poly (dI.dC) is 
strongly stimulated by DEAE-F. Thus at 20 pg/reac- 
tion mixt. of DEAE-F the incorporation of 3H-dCMP 
is almost 4 times that of control. 
Table 3 shows the inhibition of template-depen- 
dent DNA polymerase activity in MSV(M) by DEAE- 
F at various concentrations. Compared to results on 
FLV, one observes that the MSV(M) system, regard- 
less of the nature of the template used, is more sensi- 
tive to DEAE-F inhibition. Thus, the poly (dA-dT) 
catalyzed reaction is totally inhibited at 5 pg concen- 
tration of DEAE-F. The magnitude of DEAE-F inhibi- 
tion of poly (rA.dT) catalyzed reaction is the same as 
observed in FLV system. However, the poly rA.(dT)iz 
catalyzed reaction in MSV(M) system is twice as sen- 
sitive towards DEAE-F as the one in FLV system. 
Even in this system DEAE-F was found to stimulate 
dGMP incorporation in the presence of poly (dI.dC). 
However, the stimulation in this system was moderate, 
and was not observed at higher concentrations 
Since the DNA-dependent (poly dA-poly dT) ac- 
tivity was found to be most sensitive to DEAE-F in- 
hibition in both the viral systems, it was of interest 
to study DEAF-F effect on other DNA-dependent re- 
actions. Table 4 shows the action of DEAE-F on the 
DNA-dependent RNA polymerase (E. coli K-12) re- 
action. 
Levels of DEAE-F that inhibit viral (MSV-M and 
FLV) DNA polymerase activity, poly (dA-dT)-depen- 
dent incorporation of TMP, more than 90% show no 
inhibition of DNA-dependent RNA synthesis in the 
E. coli system. Even at higher concentrations of 
DEAE-F it was not possible to achieve this level (more 
than 90%) of inhibition. 
The present results show that the inhibition exer- 
ted by DEAE-F against DNA polymerases from RNA 
tumor viruses is uniquely and selectively dependent 
on the type of primer-template used in the assay sys- 
tem. The wide differences between the inhibitory con- 
centrations of DNA-dependent enzymatic reactions in 
RNA tumor viruses and bacteria could be of a signifi- 
cant therapeutic value. However, it would require more 
studies on the DNA-dependent reactions in animal 
cells before one may speculate on its therapeutic supe- 
riority . Studies on these aspects are in progress in our 
laboratory. 
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Table 1 
Inhibition of reverse-transcriptas activity of RNA tumor viruses by DEAE-fluorenone. 
System DEAE-F concentration 
(&reaction mixt. (0.25 ml)) 
3H-TMP incorporation into DNA 
(cpm/reaction mixt.) 
MSV (Moloney) FLV (Friend) 
Without virions 








7 ( 3.2) 7 ( 2.6) 
31 ( 14.3) 39 ( 14.8) 
216 (100.0) 262 (100.0) 
112( 51.8) 189 ( 72.0) 
88 ( 40.5) 128 ( 48.8) 
57 ( 26.4) 81 ( 30.9) 
* Virions containing Nonidet P-40 were preincubated at room temp for 25 min with 50 &ml of pancreatic RNase. Figures in 
parentheses are percent of control. The reaction conditions are described under Materials and methods. 
Table 2 
Inhibition of DNA-polymerase activity from FLV (Friend) by DEAE-fluorenone in the presence 
of various templates. 
DEAE-F concentration* 
(fig/reaction mixt.) 
3H-TMP incorporation into DNA 
(cpmlreaction mixt.) 
poly (dA-dT) poly (rA.dT) poly rA.(dT) 12 
3H-dCMP incorporation into DNA 
(cpm/reaction mixr.) 
poly (dI.dC) 
none 2387 (100.0) 5330 (100.0) 572 (100.0) 1797 (100.0) 
5 460( 19.2) 5170 ( 97.0) 493 ( 86.2) 3707 (206.3) 
10 292 ( 12.2) 3619 ( 67.9) 317 ( 55.4) 3962 (220.4) 
20 190( 8.0) 2808 ( 52.6) 212 ( 36.5) 6842 (380.7) 
* ng/O.25 ml of reaction mixt. The figures in parentheses indicate the percent of control (without DEAE-F). The reaction condi- 
tions are described under Materials and methods. 
Table 3 
Inhibition of DNA-polymerase activity from MSV(Moloney) by DEAEfluorenone 




3H-TMP incorporation into DNA 
(cpm/reaction mixt.) 
poly (dA-dT) poly (rA.dT) ’ poly rA.(dT) ra 
3H-dGMP incorporation into DNA 
(cpm/reaction mixt.) 
poly (dI.dC) 
none 2516 (100.0) 8911(100.0) 413 (100.0) 2107 (100.0) 
5 107( 4.2) 7852 ( 88.1) 181 ( 43.8) 3336 (158.3) 
10 lOO( ‘3.9) 6466 ( 72.5) 106 ( 25.7) 3243 (153.9) 
20 67 ( 2.6) 4212 ( 47.2) 86 ( 20.8) 2660 (126.2) 
* r&0.25 ml of reaction mixt. The figures in parentheses indicate the percent of control (without DEAE-F). The reaction condi- 
tions are described under Materials and methods. 
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Table 4 
Inhibition of DNA-dependent RNA polymerase reaction (E. coli Klz) by DEAE-fluorenone. 
May 1972 





% of Control 
Without UTP, CTP and GTP - 14 
Without DNA _ 11 
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